China Pioneer Pharma Holdings Limited

Simbol: 1345.HK

HKSE

1.42

HKD

Tržna cena danes

  • 13.7445

    Razmerje P/E

  • 0.0000

    Razmerje PEG

  • 1.67B

    Kapaciteta MRK

  • 0.04%

    Donos DIV

China Pioneer Pharma Holdings Limited (1345-HK) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za China Pioneer Pharma Holdings Limited (1345.HK). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja China Pioneer Pharma Holdings Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

0124.4289402.1
254.6
468.8
197.9
276.2
309.6
317.1
260.8
781.9
59.6

balance-sheet.row.short-term-investments

01075177.2
139.6
198.5
47
50
0
0
10
60
0

balance-sheet.row.net-receivables

0448.4413.2251.8
288
269.6
310.3
526.6
450.7
413.6
545
316.6
511.5

balance-sheet.row.inventory

0417.9321.1294.9
448.7
393.6
419.7
623.4
520.2
663.2
620
419.8
295.9

balance-sheet.row.other-current-assets

0126.2186.6241.5
275.4
300.6
202.4
103.7
128.5
143.5
585.4
343.5
0.1

balance-sheet.row.total-current-assets

01106.91134.91013.1
1127.1
1234.1
1083.2
1529.8
1409.1
1537.5
2011.2
1842
867

balance-sheet.row.property-plant-equipment-net

0247.4221.691.1
80.8
55.2
46.1
52.3
49.9
76.5
103.7
17.2
11.3

balance-sheet.row.goodwill

06.26.20
0
0
0
0
0
0
42.3
0
0

balance-sheet.row.intangible-assets

030.23745.9
47
12
14.1
15.2
15.9
61.2
158.4
15.2
18.2

balance-sheet.row.goodwill-and-intangible-assets

036.443.345.9
47
12
14.1
15.2
15.9
61.2
200.7
15.2
18.2

balance-sheet.row.long-term-investments

0117.1156.282.2
80.7
139.2
52.8
92.1
109.2
67.1
65.2
77
0

balance-sheet.row.tax-assets

02.38.612
19.5
7.8
8.6
5.4
5.9
2.1
2.3
2.1
6.3

balance-sheet.row.other-non-current-assets

020.7-8.6-12
-19.5
-7.8
-8.6
-5.4
-5.9
-2.1
-2.3
-2.1
25.7

balance-sheet.row.total-non-current-assets

0424421219.2
208.5
206.4
113
159.6
175
204.8
369.6
109.4
61.6

balance-sheet.row.other-assets

0015.896.1
92.8
110.1
241.6
144.6
164.4
79.8
174
45.5
0

balance-sheet.row.total-assets

01530.91571.71328.5
1428.4
1550.6
1437.8
1834
1748.5
1822
2554.9
1996.9
928.6

balance-sheet.row.account-payables

0284.9329.3262
360.7
263.5
143.3
568.9
419.7
426.1
391.8
329.2
244.4

balance-sheet.row.short-term-debt

061.329.614
15.1
49
101.1
34.3
79.4
287.9
611.1
429.5
416.2

balance-sheet.row.tax-payables

017.839.824.9
31.8
31.3
14.5
16.4
28.6
14.8
14.7
7.3
6

balance-sheet.row.long-term-debt-total

012.780.1
0
0.1
0
4.8
11.2
15.3
8.6
0.5
0

Deferred Revenue Non Current

041.443.643.6
19.4
-7.4
0
0
1.5
0.6
0
-7
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00143.586.2
123.7
135.6
186.7
110.2
175
350.1
830.8
476.3
0.5

balance-sheet.row.total-non-current-liabilities

070.476.369.3
32.3
7.5
2
13.9
43.2
49.4
106.3
0.5
660.6

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
33.6
-660.6

balance-sheet.row.capital-lease-obligations

0148.70.2
0
0.2
4.6
10.1
14.4
17.3
9.3
26.1
0

balance-sheet.row.total-liab

0513.1549.2417.5
516.7
406.6
332
693
637.9
825.6
1328.9
839.6
715.7

balance-sheet.row.preferred-stock

0084.159
214.2
150.1
101.8
69.3
75.7
94.4
93.1
57.1
0

balance-sheet.row.common-stock

077.477.477.6
77.6
77.6
79.1
81.4
82.1
82.1
82.1
82.1
0

balance-sheet.row.retained-earnings

0634.9594.8444.2
590.5
538
433.4
361.5
297.9
202.9
181.3
175.6
88.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0929-84.1-59
-214.2
-150.1
-101.8
-69.3
-75.7
-94.4
-93.1
-57.1
-7.1

balance-sheet.row.other-total-stockholders-equity

0-634.9335.6386.2
241.4
526
592.1
766.5
806.6
807.5
957
957
130.7

balance-sheet.row.total-stockholders-equity

01006.41007.8908
909.4
1141.5
1104.6
1140.1
1110.9
998.1
1127.4
1157.6
212.1

balance-sheet.row.total-liabilities-and-stockholders-equity

01530.91571.71328.5
1428.4
1550.6
1437.8
1834
1748.5
1822
2554.9
1996.9
928.6

balance-sheet.row.minority-interest

011.314.73
2.3
2.4
1.3
0.9
-0.3
-1.6
98.6
-0.3
0.8

balance-sheet.row.total-equity

01017.81022.5911
911.7
1144
1105.9
1141.1
1110.6
996.4
1226
1157.3
212.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

0117.1231.2259.4
220.3
337.8
99.8
142.1
109.2
67.1
65.2
137
14.2

balance-sheet.row.total-debt

07437.614.1
15.1
49
101.1
39.1
90.7
303.2
619.7
429.5
416.2

balance-sheet.row.net-debt

0-40.4-176.4-210.8
-99.9
-221.3
-49.7
-187
-219
-13.9
358.9
-272.5
356.7

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju China Pioneer Pharma Holdings Limited opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010

cash-flows.row.net-income

0235.3142.652.4
104.6
84.6
278.9
237.4
174.3
261.7
238.4
206.8
123.1
96.9

cash-flows.row.depreciation-and-amortization

013.612.98.4
8.9
8.1
8.3
13.2
16.9
7.6
2.5
2.8
2.5
2

cash-flows.row.deferred-income-tax

0000
0
-385.2
194.6
-94.5
-35.1
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
-1.4
0.9
0.6
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-193.5226.3-147.3
4.8
385.3
-193.1
93.6
34.5
-296.2
-257.6
-47.7
-123.5
-1.2

cash-flows.row.account-receivables

0-16866.2-65.3
-20
180.5
-78.2
-6.7
111.6
-168.6
-130.8
0
0
0

cash-flows.row.inventory

0-25.5160.2-82.1
24.9
204.7
-114.9
100.3
-77.1
-127.6
-126.8
-56.3
-135.3
2.7

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
0
0
0
0
0
8.6
11.8
-3.8

cash-flows.row.other-non-cash-items

037.9-139.8160.8
162.3
36
141
-3.1
78.4
9.1
64.7
-41.2
-23.9
-26.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-74.3-16.6-34.9
-8.9
-0.4
-9.7
-5.2
-6.1
-39.5
-16
-12.5
-4.7
-1.3

cash-flows.row.acquisitions-net

0-26.7-2.4-20.9
0.7
-7.8
-2
-62.1
-36.1
-110.6
-28.3
0
0
0

cash-flows.row.purchases-of-investments

0-717.2-2020.3-512.9
-697.9
-270.9
-50
0
-29.6
-78.1
-115.6
-15.7
0
0

cash-flows.row.sales-maturities-of-investments

0798.11976.4570.5
542.4
50
52
0
75.2
80
143.9
0
0
0

cash-flows.row.other-investing-activites

0771.422.1
81.1
30.4
49.7
61.2
417.5
-200.6
47.3
0.7
-142.6
47.3

cash-flows.row.net-cash-used-for-investing-activites

0-138.423.9
-82.6
-198.6
-12.1
-6.1
420.9
-348.7
-112.6
-27.5
-147.3
45.9

cash-flows.row.debt-repayment

0-1.10-0.1
-4.7
-61
-127.3
-483.5
-1103.2
-663.9
-484.8
-338
-142.9
-191.5

cash-flows.row.common-stock-issued

026.910.4-2.8
0
-1.9
-15.4
-0.9
-149.5
0
1097.9
0
0
0

cash-flows.row.common-stock-repurchased

0-25.8-10.3-2.8
-19.4
-74.9
-40.8
-0.9
-149.5
0
-383.5
0
0
0

cash-flows.row.dividends-paid

0-84.7-129.9-111.9
0
-137.8
-215.3
-142.5
-187.8
-256
-229.6
-147.6
-90
-36

cash-flows.row.other-financing-activites

0-6.4-10.4-135.5
-54.4
270.7
95.4
280.9
918.4
848.9
323
400.5
339.2
142.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-91-140.3-253
-78.5
-4.8
-303.3
-346.9
-671.6
-71
706.5
-85.1
106.3
-84.6

cash-flows.row.effect-of-forex-changes-on-cash

0-0.1-0.3-0.4
0
-0.5
-1.7
3.5
2.2
-3.8
0.7
0
-0.2
0

cash-flows.row.net-change-in-cash

0-10.8109.8-155.3
119.4
-75.3
-83.5
-7.5
56.3
-441.2
642.5
8.2
-63
32.5

cash-flows.row.cash-at-end-of-period

0214224.9115
270.3
150.9
226.2
309.6
317.1
260.8
702.1
59.6
51.4
114.3

cash-flows.row.cash-at-beginning-of-period

0224.9115270.3
150.9
226.2
309.6
317.1
260.8
702.1
59.6
51.4
114.3
81.9

cash-flows.row.operating-cash-flow

093.3242.174.2
280.6
128.7
233.6
342
304.7
-17.8
47.9
120.8
-21.8
71.2

cash-flows.row.capital-expenditure

0-74.3-16.6-34.9
-8.9
-0.4
-9.7
-5.2
-6.1
-39.5
-16
-12.5
-4.7
-1.3

cash-flows.row.free-cash-flow

019225.439.4
271.8
128.3
223.9
336.8
298.5
-57.3
31.9
108.3
-26.5
69.9

Vrstica izkaza poslovnega izida

Prihodki China Pioneer Pharma Holdings Limited so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 1345.HK znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010

income-statement-row.row.total-revenue

01566.715561434.8
1332
1316
1624.3
2153.9
1790.3
1460.9
1540.4
1272.2
958.7
717.8
570.6

income-statement-row.row.cost-of-revenue

0898.4775.6662.8
724.1
636.2
991.9
1432.5
1196.9
998.3
1048.4
885.6
652
522.1
404.6

income-statement-row.row.gross-profit

0668.2780.5772
608
679.8
632.4
721.4
593.4
462.6
491.9
386.6
306.7
195.7
166.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

01.64.82.7
2.9
8.5
8.7
5.3
4
5.3
4.8
1.3
0.8
0.6
0.3

income-statement-row.row.operating-expenses

0488496.6574.6
519
543.3
541.6
428.4
324
276.8
210.3
113.5
109.4
79.1
71.1

income-statement-row.row.cost-and-expenses

01386.51272.11237.4
1243
1179.5
1533.5
1860.9
1520.8
1275.1
1258.7
999.1
761.4
601.2
475.6

income-statement-row.row.interest-income

00.610.64
6.3
12
16.3
16.3
12.9
21
23
0.7
14.4
7.5
5.8

income-statement-row.row.interest-expense

02.51.70.9
1.1
4
1.4
2.3
5.5
20
14.1
12.7
9.4
5.5
5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

046.962.314.2
22.2
10
-42.5
24.7
39.8
-53.7
20.4
21.2
-7.8
-2.1
-5.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

01.64.82.7
2.9
8.5
8.7
5.3
4
5.3
4.8
1.3
0.8
0.6
0.3

income-statement-row.row.total-operating-expenses

046.962.314.2
22.2
10
-42.5
24.7
39.8
-53.7
20.4
21.2
-7.8
-2.1
-5.3

income-statement-row.row.interest-expense

02.51.70.9
1.1
4
1.4
2.3
5.5
20
14.1
12.7
9.4
5.5
5

income-statement-row.row.depreciation-and-amortization

018.913.212.7
8.1
8.7
8.1
8.3
13.2
16.9
7.6
2.5
2.8
2.5
2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0133.5232.2187.2
73.1
138.5
149.7
284.6
242.6
260.5
284.3
251.3
214.6
125.1
102.1

income-statement-row.row.income-before-tax

0180.4294.5201.4
95.3
148.5
107.1
309.3
282.4
206.8
304.7
272.5
206.8
123.1
96.9

income-statement-row.row.income-tax-expense

051.564.560.6
43.9
44.6
22.3
28.7
43.7
34.3
43.7
36.7
21.1
26.1
21.8

income-statement-row.row.net-income

0145.7235.3142.6
52.4
104.6
84.6
278.9
237.4
174.3
261.7
238.4
186.4
95.7
70.4

Pogosto zastavljeno vprašanje

Kaj je China Pioneer Pharma Holdings Limited (1345.HK) skupna sredstva?

China Pioneer Pharma Holdings Limited (1345.HK) skupna sredstva so 1530905000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.427.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.127.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.093.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.085.

Kaj je China Pioneer Pharma Holdings Limited (1345.HK) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 145718000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 74020000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 488030000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.